If this SPL incorporates inactivated NDCs shown through the FDA initiated compliance action, They are going to be specified as such.5.two Structural Beginning Defects Valproate could cause fetal harm when administered to the pregnant girl. Pregnancy registry facts display that maternal valproate use could potentially cause neural tube defects and a